Abstract:Objective To evaluate the association between serum 25-hydroxyvitamin D (25 [OH] D) levels and the clinical severity in cerebral infarction patients, and to explore the inlfuence in prognosis of those patients who received 25 (OH) D treatment. <br> Methods Serum concentrations of 25 (OH) D were measured among 217 patients who developed acute cerebral infarction and 163 health control subjects who were free of stroke. These patients were divided into different groups based on the serum 25 (OH) D concentrations for analyzing the proportion of each group in patients with cerebral infarction and compared with healthy control group. The difference about clinical data and their correlation were evaluated among the cerebral infarction patients with different 25 (OH) D levels. All of the patients with the serum 25 (OH) D<20 ng/ml were divided into two subgroups according to whether received vitamin D therapy and compared in 1 year follow-up for indicators such as serum 25 (OH) D levels, recurrence rates of the endpoint events and average modiifed Rankin Scale scores. <br> Results The serum 25 (OH) D concentrations were signiifcantly decreased in the cerebral infarction patients compared with the healthy control group, the mean value was (13.67±1.16) ng/ml and (20.11±2.05) ng/ml, respectively (P=0.001). In the cerebral infarction group, the prevalence of 25 (OH) D deficiency and sufficiency, showed obvious differences compared with the healthy control group. Compared to the serum 25 (OH) D≥20 ng/ml, the serum 25 (OH) D<20 ng/ml was more often in the cerebral infarction patients with hypertension, diabetes and coronary heart disease (P=0.010, P=0.011, P=0.037). There was a negative correlation between serum 25 (OH) D level and admission National Institutes of Health Stroke Scale (NIHSS) score in patients (r=-0.720, P=0.001). Among all of the cerebral infarction patients with serum 25 (OH) D levels<20 ng/ml, the subgroup which received vitamin D treatment had a recurrence rate of transient ischemic attack (TIA) or cerebral infarction and an average modiifed Rankin Scale score within one year, both were lower than that not received vitamin D treatment, but showing no statistically signiifcant differences (P=0.080, P=0.079). <br> Conclusion The lower serum 25 (OH) D levels in the patients with cerebral infarction were associated with the severity, but the evidence was still lacking that vitamin D treatment would reduce the occurrence of risk of ischemic stroke and improve patient prognosis.

Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community: the Shibata study

Serum uric acid and risk of stroke and its types: the Circulatory Risk in Communities Study (CIRCS)

Serum 25-hydroxyvitamin D is associated with stroke history in a reverse J-shape

Vitamin C Intake, Circulating Vitamin C and Risk of Stroke: A Meta‐Analysis of Prospective Studies

Dietary calcium intake and risks of stroke, its subtypes, and coronary heart disease in Japanese: the JPHC Study Cohort I

High serum total cholesterol levels is a risk factor of ischemic stroke for general Japanese population: the JPHC study

Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people

Serum uric acid levels and cardiovascular mortality in a general Japanese population: the Hisayama Study

The Relation of Serum Vitamin C Concentrations with Alzheimer's Disease Mortality in a National Cohort of Community-Dwelling Elderly Adults

Serum total cholesterol and fatal subarachnoid hemorrhage in 120,000 Japanese: a pooled analysis of data from 12 cohorts

Association of Serum Vitamin C Concentrations with Alzheimer’s Disease Mortality among U.S. Adults

Association Between Serum 25-Hydroxyvitamin D Level and Stroke Risk: an Analysis Based on the National Health and Nutrition Examination Survey

Vitamin D and Ischemic Stroke - Association, Mechanisms, and Therapeutics.

Clinical Study on Relationship of Serum 25-Hydroxyvitamin D and Cerebral Infarction and the Interventional Treatment

Serum 1, 5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study

Prevalence of vitamin C deficiency and its association with stroke risk among U.S. adult population: A cross-sectional analysis spanning 15 years with over 13,000 participants

Association of serum vitamin C with all-cause and cause-specific death: Data from National Health and Nutrition Examination Survey (NHANES 2003-2006)

Serum cystatin C and stroke risk: a national cohort and Mendelian randomization study

Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study

Serum L-Carnitine Levels Are Associated with First Stroke in Chinese Adults with Hypertension.

Plasma 25-Hydroxyvitamin D3 Concentrations and Incident Risk of Ischemic Stroke in Rural Chinese Adults: New Insight on Ceiling Effect.